SAFE-N-MEDTECH
SAFETY TESTING IN THE LIFE CYCLE OF NANOTECHNOLOGY-ENABLED MEDICAL TECHNOLOGIES FOR HEALTH
Nanotechnology is increasingly being utilised for the development of medical devices. As with all technological innovations that find applications in the healthcare sector, there is a need for careful assessment of potential risks and benefits. The EU-funded SAFE-N-MEDTECH project will develop an open access platform to provide the knowhow, networks and services required for the development of nanotechnology-based medical and diagnostic devices. The SAFE-N-MEDTECH platform will be directed to companies and laboratories and offer an integrated approach for assessing qualification, regulation, biocompatibility and the properties of nanomaterials. Implementation of the platform will expedite the transition of nanotechnology-based medical technologies to the market.
Total Eligible Budget
14,534,365.88 €
INL Eligible Budget
694,875.00 €
Total Funding
18,466,649.10 €
INL Funding
694,875.00 €
Start Date
01-04-2019
End Date
30-09-2023
Website
https://safenmt.com/
Type of action
IA Innovation action
Grant Agreement Id
814607
Programme
NMBP – Nanotechnologies, Advanced Materials, Biotechnology and Advanced Manufacturing and Processing
Funding Framework
HORIZON 2020
INL Role
Partner
Approval Date
24-09-2018
Main Objective